A Chinese research team has developed an AI platform called GalaxyVS that screens potential drugs in seconds.
The platform was developed by a Tsinghua University team and runs on China’s latest Tianhe supercomputers.
Its daily throughput for predicting molecular interactions is a million times higher than the current world record.
It incorporates the DrugCLIP virtual screening method, which was published in the journal Science in January.
Developers said the system could accelerate research on treatments for tumours, neurodegenerative diseases and infectious diseases.